68.94 USD
↘ 0.95 (1.35%)LIVE (AS OF 03:21 PM EDT)
CG Oncology, Inc. Common stock
CGONNASDAQ • USD
Market: OPEN
Open?$69.89
High?$71.22
Low?$67.82
Prev. Close?$69.88
Volume?800.3K
Avg. Volume?1.5M
VWAP?$69.56
Rel. Volume?0.52x
Bid / Ask
Bid?$66.00 × 600
Ask?$78.60 × 100
Spread?$12.60
Midpoint?$72.30
Valuation & Ratios
Market Cap?6.1B
Shares Out?84.4M
Float?55.6M
Float %?68.9%
P/E Ratio?N/A
P/B Ratio?8.06
EPS?-$1.91
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?24.63Strong
Quick Ratio?24.58Strong
Cash Ratio?1.05Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUED
Score50/100
P/E?N/A▾
P/B?8.06HIGH▾
P/S?1,501.44HIGH▾
P/FCF?N/A▾
EV/EBITDA?-31.9CHEAP▾
EV/Sales?1,494.14HIGH▾
Returns & Efficiency
ROE?-21.4%WEAK▾
ROA?-20.3%WEAK▾
Cash Flow & Enterprise
FCF?$-132480000
Enterprise Value?$6.0B
News
Profile
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer. The company's candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
Employees
142
Market Cap
6.1B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2024-01-25
Address
400 SPECTRUM CENTER DRIVE
IRVINE, CA 92618
Phone: (949) 419-6203
IRVINE, CA 92618
Phone: (949) 419-6203